Facilitating Trade In Vaccines And Essential Medical Supplies
Download Facilitating Trade In Vaccines And Essential Medical Supplies full books in PDF, epub, and Kindle. Read online free Facilitating Trade In Vaccines And Essential Medical Supplies ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Asian Development Bank |
Publisher | : Asian Development Bank |
Total Pages | : 86 |
Release | : 2022-03-01 |
Genre | : Health & Fitness |
ISBN | : 9292693840 |
The coronavirus disease or COVID-19 taught the world that it needs new investments and reforms to prepare for pandemics and disasters. Timely, accurate information must be available to support national and supranational responses. The guidance note offers information and insights on the global pandemic, focusing on trade facilitation and representing a snapshot in time, based on global knowledge shared in documents and online meetings. The note aims to build a shared framework to understand trade facilitation and border health in the context of the COVID-19 pandemic.
Author | : Asian Development Bank |
Publisher | : Asian Development Bank |
Total Pages | : 102 |
Release | : 2020-12-01 |
Genre | : Health & Fitness |
ISBN | : 9292625837 |
The economic and social impacts of the coronavirus disease (COVID-19) have been dramatic, and transport has played a central role in its spread. The transport sector has also enabled essential workers to get to work during the pandemic and will support the needs of the population throughout the different stages of recovery. This guidance note presents (i) the impacts of the pandemic on social and travel behaviors in Asia and the Pacific, and how the transport sector is responding; and (ii) guiding principles and good practices in transport operations to support economic recovery.
Author | : World Intellectual Property Organization |
Publisher | : WIPO |
Total Pages | : 259 |
Release | : 2013 |
Genre | : Law |
ISBN | : 9280523082 |
This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.
Author | : |
Publisher | : World Health Organization |
Total Pages | : 70 |
Release | : 2020-09-29 |
Genre | : Business & Economics |
ISBN | : 9240011870 |
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
Author | : World Health Organization |
Publisher | : World Health Organization |
Total Pages | : 62 |
Release | : 2009 |
Genre | : Medical |
ISBN | : 9241547685 |
This guidance is an update of WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics, published March 2005 (WHO/CDS/CSR/GIP/2005.5).
Author | : Monica de Bolle |
Publisher | : Peterson Institute for International Economics |
Total Pages | : 149 |
Release | : 2021-04-05 |
Genre | : Business & Economics |
ISBN | : 0881327425 |
The global health and economic threats from the COVID-19 pandemic are not yet behind us. While the development of multiple safe and highly effective vaccines in less than a year is cause for hope, several significant dangers to recovery of global health and income are still clear and present: New concerning variants of SARS-CoV-2, the virus that causes COVID-19, continue to emerge at an alarming rate in different parts of the world; at the same time, vaccine rollouts have been shockingly inefficient even in some rich countries, while much of the developing world waits in line behind them for vaccines to arrive. The Briefing covers several policy areas in which cooperative forward-looking policy action will materially improve our chances of truly escaping today's pandemic and making future pandemics less costly.
Author | : Ruchir Agarwal |
Publisher | : International Monetary Fund |
Total Pages | : 54 |
Release | : 2021-05-19 |
Genre | : Business & Economics |
ISBN | : 1513577603 |
Urgent steps are needed to arrest the rising human toll and economic strain from the COVID-19 pandemic that are exacerbating already-diverging recoveries. Pandemic policy is also economic policy as there is no durable end to the economic crisis without an end to the health crisis. Building on existing initiatives, this paper proposes pragmatic actions at the national and multilateral level to expeditiously defeat the pandemic. The proposal targets: (1) vaccinating at least 40 percent of the population in all countries by the end of 2021 and at least 60 percent by the first half of 2022, (2) tracking and insuring against downside risks, and (3) ensuring widespread testing and tracing, maintaining adequate stocks of therapeutics, and enforcing public health measures in places where vaccine coverage is low. The benefits of such measures at about $9 trillion far outweigh the costs which are estimated to be around $50 billion—of which $35 billion should be paid by grants from donors and the residual by national governments potentially with the support of concessional financing from bilateral and multilateral agencies. The grant funding gap identified by the Access to COVID-19 Tools (ACT) Accelerator amounts to about $22 billion, which the G20 recognizes as important to address. This leaves an estimated $13 billion in additional grant contributions needed to finance our proposal. Importantly, the strategy requires global cooperation to secure upfront financing, upfront vaccine donations, and at-risk investment to insure against downside risks for the world.
Author | : Owen Barder |
Publisher | : |
Total Pages | : 132 |
Release | : 2005 |
Genre | : Business & Economics |
ISBN | : |
A legacy of our generation -- Ch. 1. We need to invest more in vaccines -- Ch. 2. Promoting private investment in vaccine development -- Ch. 3. A market not a prize -- Ch. 4. Design choices -- Ch. 5. $3 billion per disease -- Ch. 6. Meeting industry requirements -- Ch. 7. How sponsors can do it.
Author | : Ilona Kickbusch |
Publisher | : Springer Science & Business Media |
Total Pages | : 382 |
Release | : 2012-12-09 |
Genre | : Medical |
ISBN | : 1461454018 |
The world’s problems are indeed world problems: social and environmental crises, global trade and politics, and major epidemics are making public health a pressing global concern. From this constantly changing scenario, global health diplomacy has evolved, at the intersection of public health, international relations, law, economics, and management—a new discipline with transformative potential. Global Health Diplomacy situates this concept firmly within the human rights dialogue and provides a solid framework for understanding global health issues and their negotiation. This up-to-the-minute guide sets out defining principles and the current agenda of the field, and examines key relationships such as between trade and health diplomacy, and between global health and environmental issues. The processes of global governance are detailed as the UN, WHO, and other multinational actors work to address health inequalities among the world’s peoples. And to ensure maximum usefulness, the text includes plentiful examples, discussion questions, reading lists, and a glossary. Featured topics include: The legal basis of global health agreements and negotiations. Global public goods as a foundation for global health diplomacy. Global health: a human security perspective. Health issues and foreign policy at the UN. National strategies for global health. South-south cooperation and other new models of development. A volume of immediate utility with a potent vision for the future, Global Health Diplomacy is an essential text for public health experts and diplomats as well as schools of public health and international affairs.
Author | : Dean T. Jamison |
Publisher | : World Bank Publications |
Total Pages | : 1449 |
Release | : 2006-04-02 |
Genre | : Medical |
ISBN | : 0821361805 |
Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.